This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Nigel Birdsall
Introduction
Nigel Birdsall is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurological disorders. His work has the potential to impact the lives of many individuals suffering from conditions such as dementia and Alzheimer's disease.
Latest Patents
Birdsall holds a patent for "Heterocyclic compounds, their preparation and their therapeutic use." This patent describes a compound of formula (I) wherein various substituents can be hydrogen, halogen, nitro, cyano, hydroxyl, thiol, amino, alkyl, haloalkyl, alkylthio, a protected or unprotected carboxyl, a protected or unprotected sulfonamide, or tetrazol. The compounds are effective for treating dementia, Alzheimer's disease, and delirium, and they also serve as sedatives. He has 1 patent to his name.
Career Highlights
Birdsall is currently associated with Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on developing therapeutic solutions that address critical health issues.
Collaborations
Throughout his career, Birdsall has collaborated with esteemed colleagues such as Sebastian Lazareno and Shinji Marumoto. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
Nigel Birdsall's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in addressing complex health challenges. His work continues to pave the way for advancements in treatments for neurological disorders.